European Pharma Group
Curated by SignalDevelops needle-free device for the administration of insulin
Overview
European Pharma Group design & develops needle-free devices for the administration of medicinal products. The company has developed, InsuJet, a needle-free insulin delivery system through the skin (transdermal). It is based on pressure mechanism and uses a spring system. The device involves a mechanism in which the insulin is pressed through the nozzle, resulting in a fine stream of insulin which can pass through the skin. The insulin is diffused by subcutaneous tissue.
Key facts
- Founded
- 2010
- Headquarters
- Amsterdam, Netherlands
- Stage
- Sign up to view
- Industry
- Life Sciences Technology
Contact
- Primary office
- Sign up to view
- Sign up to view